The Allstate CorporationALL
NYSE • Financial Services
$213.21
P/E
5.52
PEG
—
FCF Yield
—
Rev Growth YoY
+558.0% YoY
Gross Margin
—
Health Score
6/10
D/E Ratio
0.24
Confidence
LOW
Business Snapshot
The Allstate Corporation is one of the largest publicly traded personal lines property and casualty insurers in the United States, offering auto, home, life, and commercial insurance products. The company operates primarily through its Allstate, Esurance, Encompass, and Answer Financial brands, competing in a highly regulated and cyclical insurance market. Based on the available valuation ratios and price data, Allstate sits comfortably in large-cap territory, with its stock currently trading at $213.21 — near the upper end of its 52-week range of $180.00–$216.75.
Financial Health
**Score: 6/10** Allstate's balance sheet shows disciplined leverage, with a debt-to-equity ratio of just 0.24x, indicating a conservative capital structure well within normal bounds for a major insurer. Return on equity is a striking 3,947%, and net margin for the trailing twelve months registers at 1,519% — both figures are almost certainly distorted by an anomalous base-period comparison (likely a prior-year loss that makes percentage changes appear extreme) rather than reflecting genuine operating economics...
Risk Assessment
- **DATA QUALITY: Net margin of 1,519% and revenue growth of 558% are almost certainly base-effect distortions, making standard fundamental analysis unreliable without normalised figures.** - **CASH FLOW: Free cash flow is unavailable (N/A), preventing any assessment of cash generation quality or sustainability of earnings.** - **TECHNICALS: A confirmed "death cross" (50-day MA crossing below 200-day MA) is present, and MACD signal is bearish — both are classically negative momentum indicators.** - **VALUATION ANCHOR: No DCF fair value estimate is available due to absent FCF data, leaving the stock without a credible intrinsic value reference point.** - **PRICE PROXIMITY TO HIGH: At $213.21, the stock is trading within approximately 1.6% of its 52-week high of $216.75, limiting near-term upside headroom if momentum fades.** ---...